Prognostic indicators of future disease activity in patients with relapsing multiple sclerosis (MS): an analysis from the AFFIRM study

被引：0
|
作者：
Kappos, L
O'Connor, PW
Havrdova, E
Hutchinson, M
Miller, DH
Phillips, JT
Polman, CH
Lublin, FD
Giovannoni, G
Wajgt, A
Lynn, F
Toal, M
Panzara, MA
Sandrock, AW
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[3] Gen Teaching Hosp, Prague, Czech Republic
[4] St Vincents Univ Hosp, Dublin, Ireland
[5] Inst Neurol, London WC1N 3BG, England
[6] Texas Neurol, Dallas, TX USA
[7] VU Med Ctr, Amsterdam, Netherlands
[8] Mt Sinai Sch Med, New York, NY USA
[9] Silesian Med Univ, Katowice, Poland
[10] Biogen Idec Inc, Cambridge, MA USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2005年 / 238卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] Immunological indicators of disease activity and prognosis in multiple sclerosis
    Galboiz, Y
    Miller, A
    CURRENT OPINION IN NEUROLOGY, 2002, 15 (03) : 233 - 237
  • [32] Multiple sclerosis: early indicators of disease and assessing future risk
    Willis, M. D.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2020, 267 (11) : 3436 - 3438
  • [33] Multiple sclerosis: early indicators of disease and assessing future risk
    M. D. Willis
    N. P. Robertson
    Journal of Neurology, 2020, 267 : 3436 - 3438
  • [34] Clinical results from AFFIRM: A randomized, double-blind, placebo-controlled, multicenter trial to determine the efficacy and safety of natalizumab in patients with relapsing multiple sclerosis (MS)
    Polman, C
    O'Connor, P
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, D
    Phillips, JT
    Lublin, F
    Giovannoni, G
    Wajgt, A
    Lynn, F
    Toal, M
    Panzara, M
    NEUROLOGY, 2005, 64 (06) : A146 - A146
  • [35] No correlation between lymphocyte repopulation kinetics and MS disease activity following alemtuzumab treatment in patients with relapsing-remitting multiple sclerosis
    Wiendl, H.
    Brandes, D.
    Carraro, M.
    Comi, G.
    Mao-Draayer, Y.
    Izquierdo, G.
    Kim, H. -J.
    Meuth, S.
    Pardo, G.
    Sharrack, B.
    Tornatore, C.
    Ziemssen, T.
    Jacobs, A.
    Chung, L.
    Daizadeh, N.
    Van Wijmeersch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 261 - 262
  • [36] Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
    Pietro Iaffaldano
    Giuseppe Lucisano
    Tommaso Guerra
    Francesco Patti
    Eleonora Cocco
    Giovanna De Luca
    Vincenzo Brescia Morra
    Carlo Pozzilli
    Mauro Zaffaroni
    Diana Ferraro
    Claudio Gasperini
    Giuseppe Salemi
    Roberto Bergamaschi
    Giacomo Lus
    Matilde Inglese
    Silvia Romano
    Paolo Bellantonio
    Elisabetta Di Monte
    Giorgia Teresa Maniscalco
    Antonella Conte
    Alessandra Lugaresi
    Marika Vianello
    Valentina Liliana Adriana Torri Clerici
    Alessia Di Sapio
    Ilaria Pesci
    Franco Granella
    Rocco Totaro
    Girolama Alessandra Marfia
    Maura Chiara Danni
    Paola Cavalla
    Paola Valentino
    Umberto Aguglia
    Sara Montepietra
    Elisabetta Ferraro
    Alessandra Protti
    Daniele Spitaleri
    Carlo Avolio
    Milena De Riz
    Davide Maimone
    Guido Cavaletti
    Paola Gazzola
    Gioacchino Tedeschi
    Maria Sessa
    Marco Rovaris
    Franco Di Palma
    Maurizia Gatto
    Daniela Cargnelutti
    Francesca De Robertis̄
    Francesco Ottavio Logullo
    Augusto Rini
    Journal of Neurology, 2024, 271 : 1150 - 1159
  • [37] Regional neuronal activity in patients with relapsing remitting multiple sclerosis
    Baumgartner, Annette
    Frings, Lars
    Schiller, Florian
    Stich, Oliver
    Mix, Michael
    Egger, Karl
    Schluh, Gisa
    Rauer, Sebastian
    Meyer, Philipp T.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (06): : 466 - 474
  • [38] Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry
    Iaffaldano, Pietro
    Lucisano, Giuseppe
    Guerra, Tommaso
    Patti, Francesco
    Cocco, Eleonora
    De Luca, Giovanna
    Brescia Morra, Vincenzo
    Pozzilli, Carlo
    Zaffaroni, Mauro
    Ferraro, Diana
    Gasperini, Claudio
    Salemi, Giuseppe
    Bergamaschi, Roberto
    Lus, Giacomo
    Inglese, Matilde
    Romano, Silvia
    Bellantonio, Paolo
    Di Monte, Elisabetta
    Maniscalco, Giorgia Teresa
    Conte, Antonella
    Lugaresi, Alessandra
    Vianello, Marika
    Torri Clerici, Valentina Liliana Adriana
    Di Sapio, Alessia
    Pesci, Ilaria
    Granella, Franco
    Totaro, Rocco
    Marfia, Girolama Alessandra
    Danni, Maura Chiara
    Cavalla, Paola
    Valentino, Paola
    Aguglia, Umberto
    Montepietra, Sara
    Ferraro, Elisabetta
    Protti, Alessandra
    Spitaleri, Daniele
    Avolio, Carlo
    De Riz, Milena
    Maimone, Davide
    Cavaletti, Guido
    Gazzola, Paola
    Tedeschi, Gioacchino
    Sessa, Maria
    Rovaris, Marco
    Di Palma, Franco
    Gatto, Maurizia
    Cargnelutti, Daniela
    De Robertis, Francesca
    Logullo, Francesco Ottavio
    Rini, Augusto
    JOURNAL OF NEUROLOGY, 2024, 271 (03) : 1150 - 1159
  • [39] Natalizumab increases the proportion of patients free of clinical or MRI disease activity in relapsing multiple sclerosis
    Galetta, Steven
    Calabresi, Peter
    Confavreux, Christian
    Giovannoni, Gavin
    Havrdova, Eva
    Hutchinson, Michael
    Kappos, Ludwig
    Lublin, Fred
    Miller, David
    O'Connor, Paul W.
    Phillips, J.
    Polman, Chris
    Radue, Ernst-Wilhelm
    Rudick, Richard
    Stuart, William
    Wojgt, Andrzej
    Weinstock-Guttman, Bianca
    Wynn, Daniel
    Pace, Amy
    Hyde, Robert
    Kim, Richard
    Panzara, Michael
    NEUROLOGY, 2008, 70 (11) : A89 - A90
  • [40] Predicting Disease Activity for Patients with Relapsing Remitting Multiple Sclerosis Using Electronic Medical Records
    Medin, Jennie
    Joyeux, Alexandre
    Braune, Stefan
    Bergmann, Arnfin
    Rigg, John
    Wang, Lichao
    NEUROLOGY, 2016, 86
12345